These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8670742)

  • 1. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S; Sugiyama K; Lee YS; Kador PF
    Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV; Takahashi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of AL01576 concentration in rat lenses and plasma by bioassay for aldose reductase activity measurements.
    Hockwin O; Müller P; Krolczyk J; McCue BA; Mayer PR
    Ophthalmic Res; 1989; 21(4):285-91. PubMed ID: 2511536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a naphthalene cataract model in vitro.
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
    Unakar NJ; Tsui JY; Johnson MJ
    J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibitors and galactose toxicity in neonatal and maternal rat lenses.
    Unakar NJ; Tsui J; Anthony P; Johnson M
    J Ocul Pharmacol; 1993; 9(4):341-53. PubMed ID: 8106840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes.
    Tao RV; Holleschau AM; Rathbun WB
    Ophthalmic Res; 1991; 23(5):272-83. PubMed ID: 1784459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576.
    Lou MF; Dickerson JE; Chandler ML; Brazzell RK; York BM
    J Ocul Pharmacol; 1989; 5(3):233-40. PubMed ID: 2516529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ; Tsui JY; Johnson MJ
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In utero and milk-mediated effect of aldose reductase inhibitor on galactose cataracts.
    Unakar NJ; Tsui JY; Johnson M; Dang L
    Exp Eye Res; 1991 Nov; 53(5):665-76. PubMed ID: 1743265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of aldose reductase in naphthalene cataract.
    Lee AY; Chung SS
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.